Understanding DYT1 Dystonia using patient-derived neurons
Official title: Modeling DYT1 Dystonia in Patient-derived Neurons
Funded at Louisiana State Univ Hsc Shreveport · NIH-10863331 · Data updated 2026-11-12
This study is looking to better understand DYT1 dystonia by using brain cells from patients to find out what causes the condition, with the hope of developing new treatments that target the root of the problem instead of just easing the symptoms.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louisiana State Univ Hsc Shreveport NIH-funded |
| Lab location | 1 site (Shreveport, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $365,000 |
| NIH project number | 1R56NS133252-01 |
| Project ID | NIH-10863331 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with DYT1 dystonia, particularly those with the specific genetic mutation associated with the condition.
✕Less likely to help
Patients with other forms of dystonia or movement disorders unrelated to the DYT1 mutation may not benefit from this research.
What this research studies
This research aims to create new cellular models to study DYT1 dystonia, a severe form of movement disorder, by using neurons derived from patients. The project focuses on uncovering the molecular mechanisms behind the disease, which are not well understood, and current treatments only address symptoms. By utilizing patient-specific neurons that carry the genetic mutation associated with DYT1 dystonia, researchers hope to identify cellular deficits and better understand the disease's pathology. This innovative approach may lead to more effective therapies tailored to the underlying causes of dystonia.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients suffering from DYT1 dystonia by targeting the root causes of the disease.
How similar studies have gone: While there have been studies on dystonia, this approach using patient-derived neurons is relatively novel and has not been extensively tested in this context.
Where this research is happening
-
Louisiana State Univ Hsc Shreveport
Shreveport, United States Active
Researchers
- Principal investigator: Ding, Baojin — Louisiana State Univ Hsc Shreveport
- Study coordinator: Ding, Baojin
Related research
Other NIH-funded projects on the same topics.
-
Role of THAP1 in brain cell support cells shaping brain development
Aims to understand how the THAP1 protein in oligodendrocyte lineage cells helps shape the brain’s environment and myelination during development, which may relate to a movement disorder called DYT6 dystonia.
-
Leukocyte RNA biomarkers to help diagnose and monitor dystonia
A small study will look for RNA signatures in blood that could help diagnose and track dystonia in people who have the condition.
-
How a dystonia-linked protein affects brain support cells and myelin
This project looks at how the THAP1 protein linked to DYT6 dystonia changes the behavior of brain support cells and the surrounding matrix, which could affect myelination in adults with DYT-THAP1.
-
Intrathecal baclofen for children with dystonia due to brain injury
A physician-led study at Baylor College of Medicine will help determine how ITB therapy affects daily life, comfort, and mobility for children with dystonia and related condition after brain injury.
-
DYT1 Dystonia: Mouse Models to Understand TorsinA and Brain Circuits
A researcher-led project uses mouse models to explore how a genetic change in DYT1 dystonia affects brain circuits and movement.
-
Dystonia-specific brain signaling pattern in cerebellum
Aims to identify a characteristic pattern of nerve cell activity in the cerebellum that is linked to dystonia, with studies in mice and potential implications for people with the condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.